FCH
STJ

Freestone Capital Holdings’s St Jude Medical STJ Stock Holding History

Freestone Capital Holdings’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,366
Closed -$992K – 391
2016
Q4 		$992K Buy
12,366
+7,960
+181% +$632K 0.09% 194
2016
Q3 		$351K Buy
+4,406
New +$356K 0.03% 294

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Freestone Capital Holdings's STJ Position: Q1 2017 in Review

Freestone Capital Holdings sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 12,366 shares — an estimated $992K sold.

Freestone Capital Holdings first reported a position in STJ in Q3 2016 and held it in 2 quarters. The position peaked at $992K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Freestone Capital Holdings reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Freestone Capital Holdings sold 12,366 St Jude Medical shares in Q1 2017, an estimated $992K.
  • Freestone Capital Holdings first reported a position in St Jude Medical in Q3 2016 and held it in 2 quarters.
  • Freestone Capital Holdings's St Jude Medical position peaked at $992K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Freestone Capital Holdings's 13F filing for Q1 2017, filed 15 May 2017.